AI

Allostery Investments Portfolio holdings

AUM $7.85M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.85M
AUM Growth
-$61.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$443K
2
+$216K
3
+$204K
4
TRML
Tourmaline Bio
TRML
+$152K
5
TNGX icon
Tango Therapeutics
TNGX
+$98.9K

Top Sells

1
+$6.08M
2
+$5.44M
3
+$5.11M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$4.18M
5
APGE icon
Apogee Therapeutics
APGE
+$3.96M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELDN icon
26
Eledon Pharmaceuticals
ELDN
$217M
– –
-100,000
ETNB
27
DELISTED
89bio
ETNB
– –
-25,000
EWTX icon
28
Edgewise Therapeutics
EWTX
$3.21B
– –
-3,000
GOSS icon
29
Gossamer Bio
GOSS
$106M
– –
-613,028
INSM icon
30
Insmed
INSM
$30.1B
– –
-10,000
IONS icon
31
Ionis Pharmaceuticals
IONS
$11.9B
– –
-35,000
LXEO icon
32
Lexeo Therapeutics
LXEO
$484M
– –
-5,054
MDGL icon
33
Madrigal Pharmaceuticals
MDGL
$9.96B
– –
-600
PCVX icon
34
Vaxcyte
PCVX
$8.09B
– –
-32,000
PHGE icon
35
BiomX
PHGE
$10.2M
– –
-49,507
PLRX icon
36
Pliant Therapeutics
PLRX
$86.6M
– –
-441,686
RLYB icon
37
Rallybio
RLYB
$50.8M
– –
-94,029
SLNO icon
38
Soleno Therapeutics
SLNO
$1.9B
– –
-20,000
SWTX
39
DELISTED
SpringWorks Therapeutics
SWTX
– –
-52,500
TARS icon
40
Tarsus Pharmaceuticals
TARS
$2.9B
– –
-13,600
VIR icon
41
Vir Biotechnology
VIR
$1.52B
– –
-22,202
WVE icon
42
Wave Life Sciences
WVE
$2.51B
– –
-17,500
XENE icon
43
Xenon Pharmaceuticals
XENE
$4.82B
– –
-30,000
ZURA icon
44
Zura Bio
ZURA
$644M
– –
-2,329,384
ORKA
45
Oruka Therapeutics
ORKA
$1.55B
– –
-20,000
CLYM
46
Climb Bio
CLYM
$347M
– –
-244,988
1
2